Millennium Pharmaceuticals, Inc. (MLNM)

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)

An SI Board Since February 1997

Posts	SubjectMarks	Bans	Symbol
3044	135	0	MLNM

Emcee: icanpickem	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
2144	Millennium Pharmaceuticals "neutral" Monday, June 07, 2004 11:20:13 A	Icebrg	-	6/7/2004
2143	A peek at the partner negotiations for Velcade, all the way back to the ProScrip	tuck	-	6/7/2004
2142	Combined proteasome and histone deacetylase inhibition in non–small cell lung ca	Icebrg	-	6/7/2004
2141	<b>Goldman-Sachs new Research Report</b> MLNM announced positive Ph	PCSS	-	6/7/2004
2140	<<Angiomax competition is not clear cut, but Velcade slow market penetrati	Miljenko Zuanic	-	6/7/2004
2139	Millennium Announces Findings From a Phase I Clinical Trial of MLN2704 in Progre	Ian@SI	-	6/6/2004
2138	2 new PRs on MLNM website... Webcast from ASCO about to begin... ++++++++++++++	Ian@SI	-	6/6/2004
2137	A little more on Velcade and NSCLC... Public release date: 5-Jun-2004 Contact:	Ian@SI	-	6/6/2004
2136	[Statins to overcome resistance to anticancer drugs -- including Velcade] >&	tuck	-	6/5/2004
2135	<<As part of the deal, J&J will pay Millennium up to $750 million in m	Miljenko Zuanic	-	6/5/2004
2134	I should not have snipped the NSCLC excerpt from the Dow Jones story: <i>	tom pope	-	6/5/2004
2133	<<-- For VELCADE in combination with docetaxel (n=31), a partial response	Miljenko Zuanic	-	6/5/2004
2132	Also this excerpt from DJ news wires. Sounds enthusiastic enough that not all th	tom pope	-	6/5/2004
2131	Quite a few Velcade articles today, including this one: NEW ORLEANS, June 5 /PR	tom pope	-	6/5/2004
2130	<b>HEY, gooooo awayyyyyyy	tom pope	-	6/4/2004
2129	Finally, a place on SI for the disgruntled biotech investor to vent his/her frus	Edscharp	-	6/4/2004
2128	MLNM to appear on CNBC Monday Morning (10:50am I believe). Perhaps good news wi	Ian@SI	-	6/4/2004
2127	Angiomax competition is not clear cut, but Velcade slow market penetration is tr	Miljenko Zuanic	-	6/4/2004
2126	Synergistic induction of oxidative injury and apoptosis in human multiple myelom	Icebrg	-	6/4/2004
2125	From SSB: Millennium Pharmaceuticals (MLNM--$14.10; 2S) Valuation Our $16 tar	mopgcw	-	6/4/2004
2124	PRESS RELEASE: Millennium Acquires Rights to Novel Proteasome Inhibitors and Rel	manny t	-	6/2/2004
2123	Maybe it will be good news... Millennium Pharmaceuticals Announces Webcast of A	Ian@SI	-	6/1/2004
2122	PRESS RELEASE: Millennium and Schering-Plough Initiate Clinical Trial With INTEG	manny t	-	6/1/2004
2121	Tom, You're right, the premiums are higher than they've been recently	Ian@SI	-	5/31/2004
2120	Are they really that juiced, Ian? You can buy the Jun 15 straddle for about 1.85	tom pope	-	5/31/2004

Go to reply# or date (mm/dd/yy):